Inflammatory biomarkers in Alzheimer's disease plasma.
Angharad R Morgan,
Samuel Touchard,
Claire Leckey,
Caroline O'Hagan,
Alejo J Nevado-Holgado,
NIMA Consortium,
Frederik Barkhof,
Lars Bertram,
Olivier Blin,
Isabelle Bos,
Valerija Dobricic,
Sebastiaan Engelborghs,
Giovanni Frisoni,
Lutz Frölich,
Silvey Gabel,
Peter Johannsen,
Petronella Kettunen,
Iwona Kłoszewska,
Cristina Legido-Quigley,
Alberto Lleó,
Pablo Martinez-Lage,
Patrizia Mecocci,
Karen Meersmans,
José Luis Molinuevo,
Gwendoline Peyratout,
Julius Popp,
Jill Richardson,
Isabel Sala,
Philip Scheltens,
Johannes Streffer,
Hikka Soininen,
Mikel Tainta-Cuezva,
Charlotte Teunissen,
Magda Tsolaki,
Rik Vandenberghe,
Pieter Jelle Visser,
Stephanie Vos,
Lars-Olof Wahlund,
Anders Wallin,
Sarah Westwood,
Henrik Zetterberg,
Simon Lovestone,
B Paul Morgan,
Annex: NIMA–Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer's Disease
Jul 23, 2019
INTRODUCTION: Plasma biomarkers for Alzheimer's disease (AD) diagnosis/stratification are a "Holy Grail" of AD research and intensively sought; however, there are no well-established plasma markers. METHODS: A hypothesis-led...